|
2025-04-24 |
2025-04-23 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
1,000
+35.3%
2.98
USD 148,950
|
1,000
+35.3%
|
2.98
|
USD 100,000
|
|
|
2025-04-24 |
2025-04-22 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
1,000
+10.9%
3.00
USD 900,000
|
1,000
+10.9%
|
3.00
|
USD 100,000
|
|
|
2025-04-02 |
2025-04-02 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
15,209
+0.6%
4.04
USD 61,408
|
15,209
+0.6%
|
4.04
|
USD 61,408
|
|
|
2025-04-02 |
2025-03-31 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
19,566
+0.7%
4.38
USD 85,668
|
19,566
+0.7%
|
4.38
|
USD 85,668
|
|
|
2025-04-28 |
2025-03-27 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
1,000
+13.3%
5.19
USD 86,089
|
1,000
+13.3%
|
5.19
|
USD 100,000
|
|
|
2025-04-28 |
2025-03-26 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
1,000
+19.5%
5.04
USD 102,841
|
1,000
+19.5%
|
5.04
|
USD 100,000
|
|
|
2025-03-27 |
2025-03-26 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
20,407
+19.5%
5.04
USD 102,841
|
20,407
+19.5%
|
5.04
|
USD 102,841
|
|
|
2025-03-20 |
2025-03-20 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
30,600
+1.1%
5.61
USD 171,767
|
30,600
+1.1%
|
5.61
|
USD 171,767
|
|
|
2025-03-20 |
2025-03-19 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
25,000
+0.9%
4.94
USD 123,390
|
25,000
+0.9%
|
4.94
|
USD 123,390
|
|
|
2025-03-20 |
2025-03-18 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
44,341
+1.7%
4.73
USD 209,618
|
44,341
+1.7%
|
4.73
|
USD 209,618
|
|
|
2025-03-20 |
2025-03-18 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
18,000
+0.7%
4.60
USD 82,800
|
18,000
+0.7%
|
4.60
|
USD 82,800
|
|
|
2025-02-28 |
2025-02-28 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
85,068
+3.4%
4.60
USD 391,015
|
85,068
+3.4%
|
4.60
|
USD 391,015
|
|
|
2025-02-28 |
2025-02-27 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
86,802
+3.6%
4.46
USD 387,094
|
86,802
+3.6%
|
4.46
|
USD 387,094
|
|
|
2025-02-28 |
2025-02-26 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
164,886
+7.3%
4.01
USD 660,979
|
164,886
+7.3%
|
4.01
|
USD 660,979
|
|
|
2024-07-31 |
2024-07-30 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
85,800
+3.9%
7.15
USD 613,470
|
85,800
+3.9%
|
7.15
|
USD 613,470
|
|
|
2024-07-18 |
2024-07-18 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
80,718
+3.8%
9.11
USD 735,736
|
80,718
+3.8%
|
9.11
|
USD 735,736
|
|
|
2024-07-18 |
2024-07-17 |
B
Purchase
|
Leonard Braden Michael
Large shareholder
|
135,546
+6.9%
7.75
USD 1,049,926
|
135,546
+6.9%
|
7.75
|
USD 1,049,926
|
|
|
2024-02-09 |
2024-02-07 |
B
Purchase
|
Scopa James Paul
Non-Executive Director
|
100,000
+inf%
1.35
USD 135,000
|
100,000
+inf%
|
1.35
|
USD 135,000
|
|
|
2024-02-09 |
2024-02-07 |
B
Purchase
|
Lupher, Jr. Mark L.
Non-Executive Director
|
130,000
+inf%
1.35
USD 175,500
|
130,000
+inf%
|
1.35
|
USD 175,500
|
|
|
2023-09-18 |
2023-09-15 |
S
Sale
|
Seyedkazemi Setareh
Chief Development Officer
Officer
|
130
-0.3%
1.55
USD 201
|
130
-0.3%
|
1.55
|
USD 201
|
|
|
2023-09-18 |
2023-09-15 |
PS
Planned sale
|
Seyedkazemi Setareh
Chief Development Officer
Officer
|
6,071
-11.3%
1.52
USD 9,228
|
6,071
-11.3%
|
1.52
|
USD 9,228
|
|
|
2023-06-09 |
2023-06-07 |
B
Purchase
|
Rubinstein Linda M
Chief Financial Officer
Officer
|
100,000
+inf%
1.45
USD 145,490
|
100,000
+inf%
|
1.45
|
USD 145,490
|
|
|
2023-03-17 |
2023-03-15 |
PS
Planned sale
|
Soparkar Peter
Chief Operating Officer
Officer
|
13,360
-4.8%
0.78
USD 10,442
|
13,360
-4.8%
|
0.78
|
USD 10,442
|
|
|
2023-03-17 |
2023-03-15 |
PS
Planned sale
|
Fischer Laurent
CEO, President and Director
Executive Director
|
41,239
-5.6%
0.78
USD 32,232
|
41,239
-5.6%
|
0.78
|
USD 32,232
|
|
|
2023-03-17 |
2023-03-15 |
PS
Planned sale
|
Riley Brigit
Chief Scientific Officer
Officer
|
7,299
-5.9%
0.78
USD 5,705
|
7,299
-5.9%
|
0.78
|
USD 5,705
|
|
|
2022-09-21 |
2022-09-19 |
PS
Planned sale
|
Fischer Laurent
CEO, President and Director
Executive Director
|
41,082
-5.3%
1.07
USD 43,941
|
41,082
-5.3%
|
1.07
|
USD 43,941
|
|
|
2022-09-21 |
2022-09-19 |
PS
Planned sale
|
Soparkar Peter
See Remarks section
Officer
|
13,305
-4.6%
1.07
USD 14,232
|
13,305
-4.6%
|
1.07
|
USD 14,232
|
|
|
2022-09-21 |
2022-09-19 |
PS
Planned sale
|
Riley Brigit
Chief Scientific Officer
Officer
|
7,266
-5.8%
1.07
USD 7,772
|
7,266
-5.8%
|
1.07
|
USD 7,772
|
|
|
2022-09-21 |
2022-09-19 |
S
Sale
|
Seyedkazemi Setareh
Chief Development Officer
Officer
|
6,058
-11.2%
1.07
USD 6,480
|
6,058
-11.2%
|
1.07
|
USD 6,480
|
|
|
2022-09-21 |
2022-09-19 |
S
Sale
|
Beckman Richard
Chief Medical Officer
Officer
|
4,272
-9.9%
1.07
USD 4,570
|
4,272
-9.9%
|
1.07
|
USD 4,570
|
|
|
2022-05-24 |
2022-05-23 |
B
Purchase
|
Seyedkazemi Setareh
Chief Development Officer
Officer
|
20,000
+3333.3%
0.84
USD 16,800
|
20,000
+3333.3%
|
0.84
|
USD 16,800
|
|
|
2022-05-19 |
2022-05-17 |
B
Purchase
|
Beckman Richard
Chief Medical Officer
Officer
|
10,000
+inf%
0.82
USD 8,228
|
10,000
+inf%
|
0.82
|
USD 8,228
|
|
|
2022-05-17 |
2022-05-17 |
B
Purchase
|
D'Souza Rupert
Chief Financial Officer
Officer
|
10,000
+92.2%
0.83
USD 8,272
|
10,000
+92.2%
|
0.83
|
USD 8,272
|
|
|
2022-05-18 |
2022-05-16 |
B
Purchase
|
Svoronos Dawn
Non-Executive Director
|
30,000
+150.0%
0.85
USD 25,578
|
30,000
+150.0%
|
0.85
|
USD 25,578
|
|
|
2022-05-17 |
2022-05-13 |
B
Purchase
|
D'Souza Rupert
Chief Financial Officer
Officer
|
10,000
+1176.5%
0.86
USD 8,585
|
10,000
+1176.5%
|
0.86
|
USD 8,585
|
|
|
2022-04-22 |
2022-04-20 |
B
Purchase
|
Fischer Laurent
CEO, President and Director
Executive Director
|
25,000
+3.4%
1.11
USD 27,800
|
25,000
+3.4%
|
1.11
|
USD 27,800
|
|
|
2022-04-20 |
2022-04-19 |
B
Purchase
|
Soparkar Peter
See Remarks section
Officer
|
21,750
+8.4%
1.14
USD 24,795
|
21,750
+8.4%
|
1.14
|
USD 24,795
|
|
|
2022-04-20 |
2022-04-19 |
B
Purchase
|
Soparkar Peter
See Remarks section
Officer
|
175
+0.1%
1.14
USD 199
|
175
+0.1%
|
1.14
|
USD 199
|
|
|
2021-12-10 |
2021-12-09 |
B
Purchase
|
Fischer Laurent
CEO, President and Director
Executive Director
|
14,323
+2.0%
1.85
USD 26,498
|
14,323
+2.0%
|
1.85
|
USD 26,498
|
|
|
2021-12-10 |
2021-12-08 |
PP
Planned purchase
|
Fischer Laurent
CEO, President and Director
Executive Director
|
10,677
+1.5%
1.79
USD 19,112
|
10,677
+1.5%
|
1.79
|
USD 19,112
|
|
|
2021-12-10 |
2021-12-08 |
PP
Planned purchase
|
Soparkar Peter
See Remarks section
Officer
|
25,000
+10.7%
1.91
USD 47,750
|
25,000
+10.7%
|
1.91
|
USD 47,750
|
|
|
2021-11-17 |
2021-11-15 |
S
Sale
|
Scopa James Paul
Non-Executive Director
|
50,000
-93.7%
2.18
USD 109,000
|
50,000
-93.7%
|
2.18
|
USD 109,000
|
|
|
2021-10-04 |
2021-09-30 |
S
Sale
|
Clark Julie
Chief Medical Officer
Officer
|
4,766
-2.8%
2.17
USD 10,342
|
4,766
-2.8%
|
2.17
|
USD 10,342
|
|
|
2021-04-01 |
2021-03-31 |
B
Purchase
|
Svoronos Dawn
Non-Executive Director
|
20,000
+inf%
10.02
USD 200,338
|
20,000
+inf%
|
10.02
|
USD 200,338
|
|
|
2021-03-24 |
2021-03-24 |
B
Purchase
|
Machado Patrick
Non-Executive Director
|
10,000
+12.8%
9.92
USD 99,196
|
10,000
+12.8%
|
9.92
|
USD 99,196
|
|
|
2021-03-24 |
2021-03-24 |
B
Purchase
|
Fischer Laurent
CEO and Director
Executive Director
|
10,000
+61.4%
9.88
USD 98,780
|
10,000
+61.4%
|
9.88
|
USD 98,780
|
|
|
2021-02-11 |
2021-02-09 |
S
Sale
|
PATTERSON LEONE D
President and CFO
Officer
|
62
-0.1%
14.14
USD 877
|
62
-0.1%
|
14.14
|
USD 877
|
|
|
2021-02-11 |
2021-02-09 |
S
Sale
|
PATTERSON LEONE D
President and CFO
Officer
|
12,471
-11.3%
14.10
USD 175,841
|
12,471
-11.3%
|
14.10
|
USD 175,841
|
|
|
2021-01-19 |
2021-01-15 |
B
Purchase
|
Machado Patrick
Non-Executive Director
|
10,000
+14.7%
11.52
USD 115,174
|
10,000
+14.7%
|
11.52
|
USD 115,174
|
|
|
2021-01-19 |
2021-01-15 |
B
Purchase
|
Fischer Laurent
CEO and Director
Executive Director
|
8,600
+111.8%
11.53
USD 99,191
|
8,600
+111.8%
|
11.53
|
USD 99,191
|
|
|
2020-08-19 |
2020-08-17 |
PP
Planned purchase
|
Soparkar Peter
Chief Legal Officer
Officer
|
7,692
+256.4%
13.00
USD 99,996
|
7,692
+256.4%
|
13.00
|
USD 99,996
|
|
|
2020-08-19 |
2020-08-17 |
B
Purchase
|
Fischer Laurent
CEO and Director
Executive Director
|
7,692
+inf%
13.00
USD 99,996
|
7,692
+inf%
|
13.00
|
USD 99,996
|
|
|
2020-07-22 |
2020-07-20 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
5,000
-1.8%
17.60
USD 87,978
|
5,000
-1.8%
|
17.60
|
USD 87,978
|
|
|
2020-06-23 |
2020-06-22 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
23,605
-7.9%
25.06
USD 591,617
|
23,605
-7.9%
|
25.06
|
USD 591,617
|
|
|
2020-06-18 |
2020-06-18 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
11,127
-3.9%
25.01
USD 278,329
|
11,127
-3.9%
|
25.01
|
USD 278,329
|
|
|
2020-06-18 |
2020-06-17 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
268
-0.1%
25.01
USD 6,703
|
268
-0.1%
|
25.01
|
USD 6,703
|
|
|
2020-06-17 |
2020-06-16 |
S
Sale
|
PATTERSON LEONE D
President
Officer
|
13,171
-10.7%
24.68
USD 325,060
|
13,171
-10.7%
|
24.68
|
USD 325,060
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
159
-0.1%
23.59
USD 3,751
|
159
-0.1%
|
23.59
|
USD 3,751
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
3,425
-1.2%
23.00
USD 78,787
|
3,425
-1.2%
|
23.00
|
USD 78,787
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
1,416
-0.5%
21.93
USD 31,047
|
1,416
-0.5%
|
21.93
|
USD 31,047
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
5,000
-1.8%
21.01
USD 105,042
|
5,000
-1.8%
|
21.01
|
USD 105,042
|
|
|
2020-05-22 |
2020-05-20 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
1,401
-0.5%
20.01
USD 28,030
|
1,401
-0.5%
|
20.01
|
USD 28,030
|
|
|
2020-05-20 |
2020-05-18 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
300
-0.1%
19.03
USD 5,709
|
300
-0.1%
|
19.03
|
USD 5,709
|
|
|
2020-05-20 |
2020-05-18 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
4,700
-1.7%
18.11
USD 85,124
|
4,700
-1.7%
|
18.11
|
USD 85,124
|
|
|
2020-05-20 |
2020-05-06 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
25,000
-8.3%
20.03
USD 500,668
|
25,000
-8.3%
|
20.03
|
USD 500,668
|
|
|
2020-05-08 |
2020-05-06 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
20,000
-13.9%
20.02
USD 400,400
|
20,000
-13.9%
|
20.02
|
USD 400,400
|
|
|
2020-05-20 |
2020-05-05 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
10,000
-3.5%
16.26
USD 162,573
|
10,000
-3.5%
|
16.26
|
USD 162,573
|
|
|
2020-03-25 |
2020-03-20 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
39,526
-24.3%
10.17
USD 401,908
|
39,526
-24.3%
|
10.17
|
USD 401,908
|
|
|
2020-03-18 |
2020-03-17 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
474
-0.3%
10.02
USD 4,749
|
474
-0.3%
|
10.02
|
USD 4,749
|
|
|
2020-02-20 |
2020-02-18 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
5,000
-1.9%
16.23
USD 81,156
|
5,000
-1.9%
|
16.23
|
USD 81,156
|
|
|
2020-02-14 |
2020-02-14 |
B
Purchase
|
Scopa James Paul
Non-Executive Director
|
10,000
+50.0%
13.75
USD 137,500
|
10,000
+50.0%
|
13.75
|
USD 137,500
|
|
|
2020-02-14 |
2020-02-12 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
10,000
-3.7%
15.07
USD 150,690
|
10,000
-3.7%
|
15.07
|
USD 150,690
|
|
|
2019-12-26 |
2019-12-23 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
40,000
-14.9%
10.72
USD 428,800
|
40,000
-14.9%
|
10.72
|
USD 428,800
|
|
|
2019-05-06 |
2019-05-06 |
B
Purchase
|
Scopa James Paul
Non-Executive Director
|
20,000
+inf%
6.71
USD 134,200
|
20,000
+inf%
|
6.71
|
USD 134,200
|
|
|
2015-06-17 |
2015-06-15 |
PS
Planned sale
|
Gasmi Mehdi
SVP,Pharmaceutical Development
Officer
|
500
-6.7%
39.86
USD 19,931
|
500
-6.7%
|
39.86
|
USD 19,931
|
|
